Buy Like Buffett
Watchlist

Flagship explainer

How Renalytix plc makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$2.3M · 100%Cost of revenue$2.1M · 93%Gross profit$156000 · 7%Operating income−$29.6M · −1293%Income before tax−$33.5M · −1461%Income tax$4000 · 0%Net income−$33.5M · −1462%As of 2024-06-30 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$2.3M100%
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
Cost of revenue$2.1M93%
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
$1560007%
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
−$29.6M−1293%
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
Income before tax−$33.5M−1461%
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
Income tax$40000%
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
−$33.5M−1462%
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
Source:
  • 10-K · FY 2024Filing detailsAccession 0000950170-24-110315 · filed Sep 30, 2024
· event Jun 30, 2024 · retrieved Sep 4, 2026 · annual-row source set
Embed this chart

View the full Renalytix plc analysis at Buy Like Buffett